ArticleMultiple sclerosis journal - experimental, translational and clinical
Optimizing premedications for multiple sclerosis patients treated with ocrelizumab: A randomized controlled trial.
Naghmeh Abbasi Kasbi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.